SGLT2 inhibitors in T2D and associated comorbidities — differentiating within the class
- DOI
- 10.1186/s12902-019-0387-y
- Published
- 2019-06-17
- Container
- BMC Endocrine Disorders
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12902-019-0387-y,
title = {SGLT2 inhibitors in T2D and associated comorbidities — differentiating within the class},
author = {Guntram Schernthaner and Heinz Drexel and Evgeny Moshkovich and Birute Zilaitiene and Emil Martinka and Leszek Czupryniak and Tamás Várkonyi and Andrej Janež and Kristine Ducena and Katarina Lalić and Tsvetalina Tankova and Martin Prázný and Lea Smirčić Duvnjak and Olga Sukhareva and Harald Sourij},
year = {2019},
journal = {BMC Endocrine Disorders},
doi = {10.1186/s12902-019-0387-y},
url = {https://doi.org/10.1186/s12902-019-0387-y}
}RIS
TY - JOUR TI - SGLT2 inhibitors in T2D and associated comorbidities — differentiating within the class AU - Guntram Schernthaner AU - Heinz Drexel AU - Evgeny Moshkovich AU - Birute Zilaitiene AU - Emil Martinka AU - Leszek Czupryniak AU - Tamás Várkonyi AU - Andrej Janež AU - Kristine Ducena AU - Katarina Lalić AU - Tsvetalina Tankova AU - Martin Prázný AU - Lea Smirčić Duvnjak AU - Olga Sukhareva AU - Harald Sourij PY - 2019 JO - BMC Endocrine Disorders DO - 10.1186/s12902-019-0387-y UR - https://doi.org/10.1186/s12902-019-0387-y ER -
APA
Schernthaner, G., Drexel, H., Moshkovich, E., Zilaitiene, B., Martinka, E., Czupryniak, L., Várkonyi, T., Janež, A., Ducena, K., Lalić, K., Tankova, T., Prázný, M., Duvnjak, L. S., Sukhareva, O., & Sourij, H. (2019). SGLT2 inhibitors in T2D and associated comorbidities — differentiating within the class. BMC Endocrine Disorders. https://doi.org/10.1186/s12902-019-0387-y
Source records
- crossref · retrieved 2026-09-26T07:42:58.371Z